Ocean Bio-Chem, Inc.

Financial performance has remained strong, with revenue growing from $21.48M in Q3 2021 to $15.21M in Q2 2022. Gross profit continued to perform well, with margins at 35% in the latest quarter. Operating income reached -$329388.00 in Q2 2022, holding a steady -2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $131686.00. Net income dropped to -$321395.00, keeping EPS at -$0.03. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.